by Jane Schumacher | Apr 11, 2022
AMR Industry Alliance and its Progress Report have been featured in Health Europa Quarterly: Progress being made on AMR, but marketplace reforms needed “AMR Industry Alliance discusses the findings from their latest progress report, which pays heed to the...
by Morgane De Pol | Jan 31, 2020
This article was first published in STAT on 30 January 2020 by Steve Brooks and Alba Tiley In a world challenged by microbes resistant to antibiotics, many medical interventions that rely on these medicines to ward off infection — chemotherapy, organ transplants,...
by Morgane De Pol | Jan 30, 2020
700,000 people die from drug-resistant infections – so why do antibiotic companies face bankruptcy? This article was first published in the NZZamSonntag on 26 January 2020 by Birgit Voigt The starting point is paradoxical in several ways. Antibiotics are essential...
by Morgane De Pol | Jan 25, 2020
This article was published in Pharma Boardroom on 16 January 2020. Opinion by Greg Frank. Drug-resistant superbugs are evolving at a rapid pace. In fact, it is estimated that 700,000 people die from drug-resistant infections each year. Without urgent action, that...
by Morgane De Pol | Jan 25, 2020
This article was published in Devex 20 January 2020. Opinion by Serufusa Sekidde. Despite its magnitude, lack of access to antibiotics is a largely overlooked public health issue. 5.7 million people, including 1 million children, are dying annually from...
